Literature DB >> 19412634

Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas.

Jens Waldmann1, Emily P Slater, Peter Langer, Malte Buchholz, Annette Ramaswamy, Martin K Walz, Kurt W Schmid, Georg Feldmann, Detlef K Bartsch, Volker Fendrich.   

Abstract

BACKGROUND: One of the best known functions of the zinc-finger transcription factor Snail is to induce epithelial-mesenchymal transition (EMT). Twist, a target genes of Snail, is known to promote the development of distant metastases in mice. Increasing evidence suggests that EMT plays a pivotal role in tumor progression and metastatic spread.
METHODS: Snail, Twist, and E-cadherin expression were assessed by immunohistochemistry and real-time quantitative reverse transcriptase-polymerase chain reaction in 12 malignant and 35 benign pheochromocytomas (PCC). Data were correlated with clinical characteristics and genetics.
RESULTS: We found Snail expression in 13 (28%) of 47 primary PCC samples. Twist was expressed in 31 (66%) of 47 cases. Only one of 47 PCC showed E-cadherin expression. We observed Snail expression in 7 (58%) of 12 malignant PCC, whereas only 6 (17%) of 35 apparently benign PCC revealed Snail expression (P = 0.01). Furthermore, 11 (92%) of 12 malignant PCC, but only 20 (57%) of 35 benign PCC, revealed Twist expression (P = 0.03). Interestingly, all five metastases showed Snail and Twist expression. In normal adrenal medulla, Snail, Twist, and E-cadherin expression could not be detected.
CONCLUSIONS: We describe for the first time that EMT markers Snail and Twist are expressed in PCC and that their expression is associated with malignancy. Our study supports a role for EMT in the malignant transformation of PCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412634     DOI: 10.1245/s10434-009-0480-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

Review 1.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

Review 2.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

3.  1,25(OH)2 D3 inhibited Th17 cells differentiation via regulating the NF-κB activity and expression of IL-17.

Authors:  Dong Sun; Fei Luo; Jun-Chao Xing; Fei Zhang; Jian-Zhong Xu; Ze-Hua Zhang
Journal:  Cell Prolif       Date:  2018-04-24       Impact factor: 6.831

Review 4.  Metastatic paraganglioma.

Authors:  Stephanie M J Fliedner; Hendrik Lehnert; Karel Pacak
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

5.  Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.

Authors:  Uma Shankavaram; Stephanie M J Fliedner; Abdel G Elkahloun; Jenifer J Barb; Peter J Munson; Thanh T Huynh; Joey C Matro; Hana Turkova; W Marston Linehan; Henri J Timmers; Arthur S Tischler; James F Powers; Ronald de Krijger; Bora E Baysal; Martina Takacova; Silvia Pastorekova; David Gius; Hendrik Lehnert; Kevin Camphausen; Karel Pacak
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

6.  DNA methylation is associated with transcription of Snail and Slug genes.

Authors:  Ying Chen; Kai Wang; Chao-Nan Qian; Richard Leach
Journal:  Biochem Biophys Res Commun       Date:  2012-12-19       Impact factor: 3.575

7.  Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.

Authors:  Cong-Chong Yang; Li-Fang Zhu; Xiao-Hui Xu; Tian-Yun Ning; Jin-Hai Ye; Lai-Kui Liu
Journal:  BMC Cancer       Date:  2013-04-01       Impact factor: 4.430

8.  Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.

Authors:  Gabriele Parenti; Benedetta Zampetti; Elena Rapizzi; Tonino Ercolino; Valentino Giachè; Massimo Mannelli
Journal:  J Oncol       Date:  2012-07-17       Impact factor: 4.375

9.  Twist1 controls a cell-specification switch governing cell fate decisions within the cardiac neural crest.

Authors:  Joshua W Vincentz; Beth A Firulli; Andrea Lin; Douglas B Spicer; Marthe J Howard; Anthony B Firulli
Journal:  PLoS Genet       Date:  2013-03-21       Impact factor: 5.917

10.  Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts.

Authors:  Jingjing Quan; Moustafa Elhousiny; Newell W Johnson; Jin Gao
Journal:  Clin Exp Metastasis       Date:  2013-02-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.